WBC
RMD icon

Westpac Banking Corp’s ResMed RMD Stock Holding History

Westpac Banking Corp’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.01M Sell
22,300
-235
-1% -$58.6K 0.35% 77
2025
Q4 		$5.43M Buy
22,535
+21,325
+1,762% +$5.45M 0.34% 71
2025
Q3 		$331K Hold
1,210
– – 0.02% 295
2025
Q2 		$312K Sell
1,210
-18,556
-94% -$4.43M 0.02% 303
2025
Q1 		$4.42M Sell
19,766
-2,959
-13% -$691K 0.33% 79
2024
Q4 		$5.2M Buy
22,725
+10,754
+90% +$2.59M 0.34% 60
2024
Q3 		$2.92M Buy
11,971
+456
+4% +$102K 0.2% 125
2024
Q2 		$2.2M Buy
11,515
+10,100
+714% +$2.05M 0.17% 127
2024
Q1 		$280K Sell
1,415
-7
-0.5% -$1.28K 0.02% 312
2023
Q4 		$245K Buy
1,422
+200
+16% +$30.7K 0.02% 319
2023
Q3 		$181K Sell
1,222
-6,340
-84% -$1.15M 0.01% 386
2023
Q2 		$1.65M Sell
7,562
-18,750
-71% -$4.18M 0.12% 204
2023
Q1 		$5.76M Sell
26,312
-6,195
-19% -$1.34M 0.08% 326
2022
Q4 		$6.77M Sell
32,507
-12,282
-27% -$2.7M 0.1% 270
2022
Q3 		$9.78M Buy
44,789
+7,400
+20% +$1.68M 0.15% 185
2022
Q2 		$7.84M Buy
37,389
+4,200
+13% +$894K 0.1% 274
2022
Q1 		$8.05M Sell
33,189
-4,400
-12% -$1.06M 0.09% 289
2021
Q4 		$9.79M Buy
37,589
+24,618
+190% +$6.39M 0.1% 255
2021
Q3 		$3.42M Hold
12,971
– – 0.04% 484
2021
Q2 		$3.2M Sell
12,971
-31,618
-71% -$6.65M 0.03% 518
2021
Q1 		$8.65M Buy
44,589
+100
+0.2% +$20.1K 0.1% 273
2020
Q4 		$9.46M Sell
44,489
-67,654
-60% -$13.5M 0.11% 255
2020
Q3 		$9.24M Sell
112,143
-16,659
-13% -$3.08M 0.13% 206
2020
Q2 		$10.6M Buy
128,802
+118,655
+1,169% +$19.4M 0.16% 162
2020
Q1 		$1.49M Hold
10,147
– – 0.03% 513
2019
Q4 		$1.57M Sell
10,147
-119,941
-92% -$17.3M 0.02% 599
2019
Q3 		$2.98M Buy
130,088
+65,741
+102% +$8.61M 0.04% 462
2019
Q2 		$7.85M Sell
64,347
-135,497
-68% -$15M 0.12% 235
2019
Q1 		$8.24M Buy
199,844
+31,820
+19% +$3.28M 0.14% 199
2018
Q4 		$8.2M Buy
168,024
+42,787
+34% +$4.58M 0.14% 197
2018
Q3 		$2.3M Buy
125,237
+116,982
+1,417% +$12.8M 0.04% 419
2018
Q2 		$855K Hold
8,255
– – 0.02% 529
2018
Q1 		$813K Hold
8,255
– – 0.02% 531
2017
Q4 		$699K Hold
8,255
– – 0.02% 548
2017
Q3 		$635K Sell
8,255
-217
-3% -$16.6K 0.01% 627
2017
Q2 		$660K Hold
8,472
– – 0.01% 619
2017
Q1 		$610K Hold
8,472
– – ﹤0.01% 756
2016
Q4 		$539K Hold
8,472
– – 0.01% 702
2016
Q3 		$549K Hold
8,472
– – 0.01% 666
2016
Q2 		$536K Buy
8,472
+1,835
+28% +$108K 0.01% 716
2016
Q1 		$384K Sell
6,637
-59,900
-90% -$3.39M ﹤0.01% 717
2015
Q4 		$3.57M Sell
66,537
-2,847
-4% -$160K 0.04% 367
2015
Q3 		$3.54M Sell
69,384
-43,445
-39% -$2.34M 0.04% 365
2015
Q2 		$6.36M Buy
112,829
+104,907
+1,324% +$6.62M 0.06% 278
2015
Q1 		$642K Sell
7,922
-1,300
-14% -$84.4K 0.01% 694
2014
Q4 		$517K Hold
9,222
– – ﹤0.01% 737
2014
Q3 		$454K Hold
9,222
– – ﹤0.01% 767
2014
Q2 		$467K Sell
9,222
-160
-2% -$7.93K ﹤0.01% 765
2014
Q1 		$419K Hold
9,382
– – ﹤0.01% 752
2013
Q4 		$442K Hold
9,382
– – 0.01% 771
2013
Q3 		$496K Sell
9,382
-26,800,563
-100% -$1.3B 0.01% 731
2013
Q2 		$122M Buy
+26,809,945
New +$1.27B 1.87% 2

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Westpac Banking Corp's RMD Position: Q1 2026 in Review

Westpac Banking Corp reduced its ResMed (RMD) stake by 1% in Q1 2026, selling an estimated $58.6K and leaving 22,300 shares worth $5.01M. The position accounts for 0.35% of the portfolio, ranked #77.

Westpac Banking Corp first reported a position in RMD in Q2 2013 and has held it in 52 quarters since. The position peaked at $122M in Q2 2013. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Westpac Banking Corp held 22,300 shares of ResMed worth $5.01M as of Q1 2026.
  • Westpac Banking Corp sold 235 ResMed shares in Q1 2026, an estimated $58.6K.
  • ResMed made up 0.35% of Westpac Banking Corp's portfolio in Q1 2026, its #77 holding.
  • Westpac Banking Corp first reported a position in ResMed in Q2 2013 and has held it in 52 quarters since.
  • Westpac Banking Corp's ResMed position peaked at $122M in Q2 2013.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Westpac Banking Corp's 13F filing for Q1 2026, filed 12 May 2026.